Interestingly, BLCA patients with higher expression of NDC80 complex components exhibited increased expression of these immune checkpoint genes, although no significant differential expression was observed for CTLA4, HAVCR2, PDCD1, and TIGIT between low and high NUF2 expression groups (Figure 5A). This evidence concerns the gene CTLA4 and bladder transitional cell carcinoma.